ICLR · Healthcare · $13.0B
After-hours $161.850.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“순수 서비스 매출(직접 수수료)이 조사 결과로 5,000만 달러 이상 줄었지만, 순 수주액은 전년 대비 19% 늘어난 29억 달러를 기록했어요”
In the company's words · 2025 4분기 earnings call